11 Capital Partners LP Boosts Stock Position in Danaher Corporation $DHR

Key Points

• 11 Capital Partners LP increased its position in Danaher Corporation by 12.3% during the first quarter, holding a total of 67,176 shares worth approximately $13.77 million.
• Analysts have mixed forecasts for Danaher, with target prices ranging from $205 to $246.35 and a consensus rating of "Moderate Buy."
• Danaher reported its earnings per share at $1.80, surpassing the expected $1.64, along with a 3.4% year-over-year revenue increase to $5.94 billion.

11 Capital Partners LP grew its holdings in shares of Danaher Corporation (NYSE:DHR - Free Report) by 12.3% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 67,176 shares of the conglomerate's stock after acquiring an additional 7,357 shares during the quarter. Danaher accounts for approximately 4.6% of 11 Capital Partners LP's holdings, making the stock its 12th biggest holding. 11 Capital Partners LP's holdings in Danaher were worth $13,771,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. GHP Investment Advisors Inc. boosted its position in Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares during the period. Heck Capital Advisors LLC purchased a new stake in Danaher during the 4th quarter valued at $27,000. Sierra Ocean LLC boosted its position in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after buying an additional 76 shares during the period. Smallwood Wealth Investment Management LLC purchased a new position in Danaher during the 1st quarter valued at $31,000. Finally, Dunhill Financial LLC increased its position in Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 67 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insider Buying and Selling at Danaher

In related news, Director Teri List sold 2,778 shares of the firm's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 11.10% of the company's stock.

Danaher Price Performance

Shares of NYSE DHR traded up $1.29 during midday trading on Friday, reaching $200.32. The stock had a trading volume of 2,837,584 shares, compared to its average volume of 2,859,442. The stock has a 50-day moving average of $201.93 and a 200-day moving average of $199.37. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The company has a market capitalization of $143.44 billion, a price-to-earnings ratio of 42.62, a price-to-earnings-growth ratio of 2.79 and a beta of 0.75. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the previous year, the firm earned $1.72 earnings per share. The company's quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on DHR. Scotiabank raised shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price objective on the stock in a research report on Friday, July 11th. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Robert W. Baird increased their price objective on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. UBS Group decreased their price objective on Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. Finally, Guggenheim reissued a "buy" rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $246.35.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.